Correlation of Cerebral Metabolites with Functional Outcome in Experimental Primate Stroke Using in Vivo ¹H-Magnetic Resonance Spectroscopy

References

1. ↵
   del Zoppo GJ. Clinical trials in acute stroke: why have they not been successful? Neurology 1998;51(suppl 3):S59–61
2. Hoyte L, Kaur J, Buchan AM. Lost in translation: taking neuroprotection from animal models to clinical trials. Exp Neurol 2004;188:200–04

   CrossRefPubMedWeb of Science
3. ↵
   Wahlgren NG, Ahmed N. Neuroprotection in cerebral ischaemia: facts and fancies–the need for new approaches. Cerebrovasc Dis 2004;17(suppl 1):153–66
4. ↵
   Del Zoppo GJ, Copeland BR, Harker LA, et al. Experimental acute thrombotic stroke in baboons. Stroke 1986;17:1254–65

   Abstract/FREE Full Text
5. Liu XG, Branston NM, Kawauchi M, et al. A model of acute focal ischemia in the territory of the anterior cerebral artery in baboons. Stroke 1992;23:40–44

   Abstract/FREE Full Text
6. ↵
   Huang J, Mocco J, Choudhri TF, et al. A modified transorbital baboon model of reperfused stroke. Stroke 2000;31:3054–63

   Abstract/FREE Full Text
7. ↵
   Fukuda S, del Zoppo GJ. Models of focal cerebral ischemia in the nonhuman primate. ILAR J 2003;44:96–104

   Abstract/FREE Full Text
8. ↵
   Lake AR, Van Niekerk IJ, Le Roux CG, et al. Angiology of the brain of the baboon Papio ursinus, the vervet monkey Cercopithecus pygerithrus, and the bushbaby Galago senegalensis. Am J Anat 1990;187:277–86

   CrossRefPubMed
9. ↵
   Mack WJ, Komotar RJ, Mocco J, et al. Serial magnetic resonance imaging in experimental primate stroke: validation of MRI for pre-clinical cerebroprotective trials. Neurol Res 2003;25:846–52

   CrossRefPubMed
10. ↵
    Mack WJ, King RG, Hoh DJ, et al. An improved functional neurological examination for use in nonhuman primate studies of focal reperfused cerebral ischemia. Neurol Res 2003;25:280–84

    PubMed
11. ↵
    Plautz EJ, Barbay S, Frost SB, et al. Post-infarct cortical plasticity and behavioral recovery using concurrent cortical stimulation and rehabilitative training: a feasibility study in primates. Neurol Res 2003;25:801–10

    CrossRefPubMedWeb of Science
12. ↵
    Kertesz A, Black SE, Nicholson L, et al. The sensitivity and specificity of MRI in stroke. Neurology 1987;37:1580–85

    Abstract/FREE Full Text
13. Bryan RN, Levy LM, Whitlow WD, et al. Diagnosis of acute cerebral infarction: comparison of CT and MR imaging. AJNR Am J Neuroradiol 1991;12:611–20

    Abstract/FREE Full Text
14. Lovblad KO, Baird AE, Schlaug G, et al. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol 1997;42:164–70

    CrossRefPubMedWeb of Science
15. Barber PA, Darby DG, Desmond PM, et al. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI. Neurology 1998;51:418–26

    Abstract/FREE Full Text
16. ↵
    Moonis M, Fisher M. Imaging of acute stroke. Cerebrovasc Dis 2001;11:143–50

    CrossRefPubMed
17. ↵
    Hoehn M, Nicolay K, Franke C, et al. Application of magnetic resonance to animal models of cerebral ischemia. J Magn Reson Imaging 2001;14:491–509

    CrossRefPubMed
18. ↵
    Giroud M, Walker P, Guy F, et al. Cerebral metabolism after transient ischemic attack: A 1H MR spectroscopy study. Neurol Res 1999;21:563–65

    PubMed
19. ↵
    Parsons MW, Li T, Barber PA, et al. Combined (1)H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome. Neurology 2000;55:498–505

    Abstract/FREE Full Text
20. ↵
    Saunders DE. MR spectroscopy in stroke. Br Med Bull 2000;56:334–45

    Abstract/FREE Full Text
21. Demougeot C, Walker P, Beley A, et al. Spectroscopic data following stroke reveal tissue abnormality beyond the region of T2-weighted hyperintensity. J Neurol Sci 2002;199:73–78

    CrossRefPubMed
22. ↵
    Walker PM, Ben Salem D, Lalande A, et al. Time course of NAA T2 and ADC(w) in ischaemic stroke patients: 1H MRS imaging and diffusion-weighted MRI. J Neurol Sci 2004;220:23–28

    CrossRefPubMedWeb of Science
23. ↵
    Monsein LH, Mathews VP, Barker PB, et al. Irreversible regional cerebral ischemia: serial MR imaging and proton MR spectroscopy in a nonhuman primate model. AJNR Am J Neuroradiol 1993;14:963–70

    Abstract/FREE Full Text
24. ↵
    Roitberg B, Khan N, Tuccar E, et al. Chronic ischemic stroke model in cynomolgus monkeys: behavioral, neuroimaging and anatomical study. Neurol Res 2003;25:68–78

    CrossRefPubMedWeb of Science
25. ↵
    Arias-Mendoza F, Brown TR. In vivo measurement of phosphorous markers of disease. Dis Markers 2003;19:49–68

    PubMed
26. ↵
    Graham GD, Blamire AM, Howseman AM, et al. Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke 1992;23:333–40

    Abstract/FREE Full Text
27. ↵
    Gideon P, Henriksen O, Sperling B, et al. Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke: a proton magnetic resonance spectroscopy study. Stroke 1992;23:1566–72

    Abstract/FREE Full Text
28. ↵
    Graham GD, Blamire AM, Rothman DL, et al. Early temporal variation of cerebral metabolites after human stroke: a proton magnetic resonance spectroscopy study. Stroke 1993;24:1891–96

    Abstract/FREE Full Text
29. ↵
    Demougeot C, Marie C, Giroud M, et al. N-acetylaspartate: a literature review of animal research on brain ischaemia. J Neurochem 2004;90:776–83

    CrossRefPubMedWeb of Science
30. ↵
    Pereira AC, Saunders DE, Doyle VL, et al. Measurement of initial N-acetyl aspartate concentration by magnetic resonance spectroscopy and initial infarct volume by MRI predicts outcome in patients with middle cerebral artery territory infarction. Stroke 1999;30:1577–82

    Abstract/FREE Full Text
31. ↵
    Parsons MW, Barber PA, Desmond PM, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002;52:20–28

    CrossRefPubMedWeb of Science
32. ↵
    Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:1–15

    PubMed
33. ↵
    Spetzler RF, Selman WR, Weinstein P, et al. Chronic reversible cerebral ischemia: evaluation of a new baboon model. Neurosurgery 1980;7:257–61

    PubMed
34. ↵
    Barber PA, Demchuk AM, Hirt L, et al. Biochemistry of ischemic stroke. Adv Neurol 2003;92:151–64

    PubMed
35. ↵
    Castillo J, Rodriguez I. Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovasc Dis 2004;17(suppl 1):7–18
36. ↵
    Berkelbach van der Sprenkel JW, Luyten PR, van Rijen PC, et al. Cerebral lactate detected by regional proton magnetic resonance spectroscopy in a patient with cerebral infarction. Stroke 1988;19:1556–60

    Abstract/FREE Full Text
37. ↵
    Barker PB, Gillard JH, van Zijl PC, et al. Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology 1994;192:723–32

    PubMedWeb of Science
38. ↵
    Stengel A, Neumann-Haefelin T, Singer OC, et al. Multiple spin-echo spectroscopic imaging for rapid quantitative assessment of N-acetylaspartate and lactate in acute stroke. Magn Reson Med 2004;52:228–38

    CrossRefPubMedWeb of Science
39. Mathews VP, Barker PB, Blackband SJ, et al. Cerebral metabolites in patients with acute and subacute strokes: concentrations determined by quantitative proton MR spectroscopy. AJR Am J Roentgenol 1995;165:633–38

    PubMedWeb of Science
40. ↵
    Graham GD, Hwang JH, Rothman DL, et al. Spectroscopic assessment of alterations in macromolecule and small-molecule metabolites in human brain after stroke. Stroke 2001;32:2797–802

    Abstract/FREE Full Text
41. ↵
    Federico F, Simone IL, Lucivero V, et al. Prognostic value of proton magnetic resonance spectroscopy in ischemic stroke. Arch Neurol 1998;55:48–94
42. Graham GD, Kalvach P, Blamire AM, et al. Clinical correlates of proton magnetic resonance spectroscopy findings after acute cerebral infarction. Stroke 1995;26:225–29

    Abstract/FREE Full Text
43. ↵
    Lemesle M, Walker P, Guy F, et al. Multi-variate analysis predicts clinical outcome 30 days after middle cerebral artery infarction. Acta Neurol Scand 2000;102:11–17

    CrossRefPubMed